Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec 18;398(10318):2209-2211.
doi: 10.1016/S0140-6736(21)02799-9.

COV-BOOST: evidence to support rapid booster deployment

Victoria Hall  1 , Susan Hopkins  2
Affiliations
Comment

COV-BOOST: evidence to support rapid booster deployment

Victoria Hall et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

SH and VH declare funding from UK Department of Health and Social Care (with contributions from Governments in Northern Ireland, Wales, and Scotland) and the National Institutes for Health Research, and grant funding from the Medical Research Council for the SIREN Study.

Comment on

  • Department of Error.
    [No authors listed] [No authors listed] Lancet. 2021 Dec 18;398(10318):2246. doi: 10.1016/S0140-6736(21)02785-9. Lancet. 2021. PMID: 34922669 Free PMC article. No abstract available.

References

    1. Andrews N, Tessier E, Stowe J, et al. Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 11 in the UK. medRxiv. 2021 doi: 10.1101/2021.09.15.21263583. published online Sept 21. (preprint). - DOI
    1. Tartof SY, Slezak JM, Fischer H, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398:1407–1416. - PMC - PubMed
    1. Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. 2021 doi: 10.1056/NEJMoa2114114. published online Oct 6. - DOI - PMC - PubMed
    1. Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med. 2021;385:1393–1400. - PMC - PubMed
    1. WHO Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....